The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s immunodiagnostics market report forecasts the immunodiagnostics market size to grow to $28.29 Billion by 2027, with a CAGR (compound annual growth rate) of more than 7%.

Learn More On The Immunodiagnostics Market Report 2023 – https://www.thebusinessresearchcompany.com/report/immunodiagnostics-global-market-report

Immunodiagnostics Market Size Forecast
The global immunodiagnostics market is expected to grow from $19.77 billion in 2022 to $21.30 billion in 2023 at a compound annual growth rate (CAGR) of 7.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global immunodiagnostics market size is expected to reach $28.29 billion in 2027 at a CAGR of 7.4%.

North America held the largest immunodiagnostics market share.

Key Immunodiagnostics Market Driver ­– Increase In The Prevalence Of Infectious Diseases
According to a report issued in July 2022 by the Australian Institute of Health and Welfare, an Australia-based government institution that provides data and statistics regarding Australia’s well-being and health, over 471,000 COVID-19 instances were reported in Australia in 2021. Furthermore, in 2021, there were around 86,000 cases of chlamydia, a sexually transmitted infection, and 37,000 cases of campylobacter, a gastrointestinal sickness. As a result, the rising prevalence of infectious disorders is propelling the immunodiagnostics market forward.

Request for A Sample Of The Global Immunodiagnostics Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10093&type=smp

Key Immunodiagnostics Market Trend – Technological Advancement
To maintain their market position, major immunodiagnostics businesses are focusing on creating new technologies. Cavidi AB, a Swedish developer and marketer of viral load solutions for human immunodeficiency virus (HIV) monitoring, for example, unveiled Exazym in May 2021, a signal-generating technology that would bring ultra-sensitive detection levels to standard immunodiagnostic procedures. Traditional immunodiagnostic approaches can now achieve ultra-sensitive detection levels thanks to signal-generating technology. Cavidi Exazym is expected to advance current and future research, screenings, and diagnostic testing. Cavidi Exazym allows for the detection of biomarkers that are outside the reach of currently known diagnostic tools, allowing medical practitioners to begin treating patients even before the onset of a major illness.

Immunodiagnostics Market Segment
1) By Product: Reagents And Consumables, Instruments, Software And Services
2) By Technology: Enzyme-Linked Immunosorbent Assay, Chemiluminescence Immunoassay, Fluorescent Immunoassay, Radioimmunoassay, Rapid Test, Other Technologies
3) By Application: Infectious Diseases, Oncology And Endocrinology, Bone And Mineral Diseases, Autoimmunity Disorders, Cardiac Biomarkers, Drug Monitoring, Other Applications
4) By End User: Hospitals, Clinics, Diagnostic Laboratories, Academic And Research Institutes, Other End Users

Immunodiagnostics Market Major Players and Strategies
Major players in the immunodiagnostics market are Abbott Laboratories, Arkray Inc., bioMérieux Inc., Immunodiagnostic Systems Holdings Plc (IDS), Bio-Rad Laboratories Inc., DiaSorin S.p.A., F. Hoffmann-La Roche Ltd., Johnson & Johnson Services Inc., Siemens, Sysmex Corporation, Thermo Fisher Scientific Inc., Danaher Corporation, Qiagen N.V., Tecan Trading AG, and PerkinElmer Inc.

DiaSorin S.p.A., an Italian biotechnology business, paid $1.8 billion for Luminex Corporation in July 2021. DiaSorin gained access to Luminex’s multiplexing technology as well as a portfolio that bolstered its current offering while expanding the Group’s reach in the United States as a result of the acquisition. T Luminex Corporation is a biotechnology firm established in the United States that creates, manufactures, and sells patented biological testing methods and products for use in life sciences, transplant research, and immunodiagnostics.

The Immunodiagnostics Global Market Report 2023 covers regional data on immunodiagnostics market size, immunodiagnostics market trends and drivers, opportunities, strategies, and immunodiagnostics market competitor analysis. The countries covered in the immunodiagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Immunodiagnostics is a diagnostic approach that detects serum insulin predominantly through an antigen-antibody response. Antibodies and parasite antigens are detected using immunodiagnostic testing.

View More Reports Related To The Immunodiagnostics Market –
Veterinary Diagnostic Equipment Global Market Report 2023
Veterinary Laboratory Testing Services Global Market Report 2023
Veterinary Infectious Disease Diagnostics Global Market Report 202

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: